ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Estrogens and the Regulation of Lipid Metabolism
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 90014" data-attributes="member: 2624"><p>When it comes to heart disease associated with obesity, women (prior to the onset of menopause) are protected to a far greater extent than men. Sex hormones have been proposed as the factor that differentiates the risk. The authors of this study discuss the literature around how the endogenous sex hormones and hormone treatment approaches after menopause regulate fatty acid, triglyceride, and cholesterol metabolism to influence cardiovascular risk.</p><p></p><ul> <li data-xf-list-type="ul">The important regulatory functions of estrogen signaling pathways with regard to lipid metabolism have been in part obscured by clinical trials with hormone treatment of women after menopause, due to different formulations, routes of delivery, and pairings with progestins.</li> <li data-xf-list-type="ul">Oral hormone treatment with several estrogen preparations increases VLDL triglyceride production.</li> <li data-xf-list-type="ul">Progestins oppose this effect by stimulating VLDL clearance in both humans and animals.</li> <li data-xf-list-type="ul">Transdermal estradiol preparations do not increase VLDL production or serum triglycerides.</li> <li data-xf-list-type="ul">Many aspects of sex differences in atherosclerotic heart disease risk are influenced by the distributed actions of estrogens in the muscle, adipose, and liver.</li> <li data-xf-list-type="ul"><strong>In humans, 17&#946;-estradiol (E2) is the predominant circulating estrogen and signals through estrogen receptor alpha (ER&#945<img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite2" alt=";)" title="Wink ;)" loading="lazy" data-shortname=";)" />, estrogen receptor beta (ER&#946<img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite2" alt=";)" title="Wink ;)" loading="lazy" data-shortname=";)" />, and G-protein-coupled estrogen receptor (GPER). Over 1000 human liver genes diEsplay a sex bias in their expression, and the top biological pathways are in lipid metabolism and genes related to cardiovascular disease</strong>.</li> <li data-xf-list-type="ul">Future directions will likely rely on targeting estrogens to specific tissues or specific aspects of the signaling pathways in order to recapitulate the protective physiology of pre-menopause therapeutically after menopause.</li> </ul><p></p><p></p><p>"Role of Estrogens in the Regulation of Liver Lipid Metabolism," <em>Advances in Experimental Medicine and Biology, 2017;</em>1043:227-256, <a href="https://www.ncbi.nlm.nih.gov/pubmed/29224098/" target="_blank">https://www.ncbi.nlm.nih.gov/pubmed/29224098/</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 90014, member: 2624"] When it comes to heart disease associated with obesity, women (prior to the onset of menopause) are protected to a far greater extent than men. Sex hormones have been proposed as the factor that differentiates the risk. The authors of this study discuss the literature around how the endogenous sex hormones and hormone treatment approaches after menopause regulate fatty acid, triglyceride, and cholesterol metabolism to influence cardiovascular risk. [LIST] [*]The important regulatory functions of estrogen signaling pathways with regard to lipid metabolism have been in part obscured by clinical trials with hormone treatment of women after menopause, due to different formulations, routes of delivery, and pairings with progestins. [*]Oral hormone treatment with several estrogen preparations increases VLDL triglyceride production. [*]Progestins oppose this effect by stimulating VLDL clearance in both humans and animals. [*]Transdermal estradiol preparations do not increase VLDL production or serum triglycerides. [*]Many aspects of sex differences in atherosclerotic heart disease risk are influenced by the distributed actions of estrogens in the muscle, adipose, and liver. [*][B]In humans, 17β-estradiol (E2) is the predominant circulating estrogen and signals through estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and G-protein-coupled estrogen receptor (GPER). Over 1000 human liver genes diEsplay a sex bias in their expression, and the top biological pathways are in lipid metabolism and genes related to cardiovascular disease[/B]. [*]Future directions will likely rely on targeting estrogens to specific tissues or specific aspects of the signaling pathways in order to recapitulate the protective physiology of pre-menopause therapeutically after menopause. [/LIST] "Role of Estrogens in the Regulation of Liver Lipid Metabolism," [I]Advances in Experimental Medicine and Biology, 2017;[/I]1043:227-256, [URL]https://www.ncbi.nlm.nih.gov/pubmed/29224098/[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Estrogens and the Regulation of Lipid Metabolism
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top